Sandy Spring Bank Vaxxinity, Inc. Transaction History

Sandy Spring Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.31 - $2.62 $131 - $262	100 New	100 $0
Q1 2022 May 03, 2022	SELL	$3.7 - $8.6 $370 - $860	-100 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.55 - $18.46 $555 - $1,846	100 New	100 $1,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.